{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:41:55Z","timestamp":1790509315490,"version":"4.1.0"},"reference-count":49,"publisher":"Impact Journals, LLC","issue":"26","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,9,9]]},"DOI":"10.18632\/oncotarget.4854","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T04:47:30Z","timestamp":1442292450000},"page":"23026-23035","source":"Crossref","is-referenced-by-count":12,"title":["Loss of tumor suppressors KAI1 and p27 identifies a unique subgroup of primary melanoma patients with poor prognosis"],"prefix":"10.18632","volume":"6","author":[{"given":"Guohong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Department of Pathology, Shantou University Medical College, Shantou, Guangdong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangdi","family":"Chen","sequence":"additional","affiliation":[{"name":"Bioelectromagnetics Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gholamreza","family":"Ardekani","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Rotte","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Martinka","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"McElwee","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, 2nd Affiliated Hospital, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, 2nd Affiliated Hospital, Dalian Medical University, Dalian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, Vancouver Coastal Health Research Institute, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Department of Dermatology, 2nd Affiliated Hospital, Dalian Medical University, Dalian, China"},{"name":"Dermatologic Oncology Program, British Columbia Cancer Agency, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,7,14]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1535-6108(02)00161-7","article-title":"Focus on melanoma","volume":"2","author":"Polsky","year":"2002","journal-title":"Cancer Cell"},{"key":"2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Mihm","year":"2006","journal-title":"N Engl J Med"},{"key":"3","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Lebbe","year":"2011","journal-title":"The New England journal of medicine"},{"key":"4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0140-6736(12)60868-X","article-title":"Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial","volume":"380","author":"Mauch","year":"2012","journal-title":"Lancet"},{"key":"5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa1203421","article-title":"Improved survival with MEK inhibition in BRAF-mutated melanoma","volume":"367","author":"Larkin","year":"2012","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Lutzky","year":"2010","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.mayocp.2014.02.009","article-title":"Melanoma resistance: a bright future for academicians and a challenge for patient advocates","volume":"89","author":"Carlson","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"8","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","article-title":"Cutaneous melanoma","volume":"383","author":"Robert","year":"2014","journal-title":"Lancet"},{"key":"9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1477-7819-9-40","article-title":"Thick primary melanoma has a heterogeneous tumor biology: an institutional series","volume":"9","author":"Kane","year":"2011","journal-title":"World J Surg Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.2006.08.1463","article-title":"Identification of high-risk patients among those diagnosed with thin cutaneous melanomas","volume":"25","author":"Guerry","year":"2007","journal-title":"J Clin Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.sla.0000090446.63327.40","article-title":"Thin melanomas: predictive lethal characteristics from a 30-year clinical experience","volume":"238","author":"Seigler","year":"2003","journal-title":"Ann Surg"},{"key":"12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1586\/14737159.3.3.303","article-title":"Biomarkers in melanoma: staging, prognosis and detection of early metastases","volume":"3","author":"Ross","year":"2003","journal-title":"Expert Rev Mol Diagn"},{"key":"13","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1016\/j.humpath.2013.02.022","article-title":"Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma","volume":"44","author":"Slominski","year":"2013","journal-title":"Hum Pathol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1152\/physrev.00044.2003","article-title":"Melanin pigmentation in mammalian skin and its hormonal regulation","volume":"84","author":"Wortsman","year":"2004","journal-title":"Physiol Rev"},{"key":"15","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-148X.2011.00898.x","article-title":"L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions","volume":"25","author":"Pawelek","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Weinberg","year":"2011","journal-title":"Cell"},{"key":"17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ccr.2011.05.025","article-title":"Proinvasion metastasis drivers in early-stage melanoma are oncogenes","volume":"20","author":"Zeid","year":"2011","journal-title":"Cancer Cell"},{"key":"18","doi-asserted-by":"crossref","first-page":"e10770","DOI":"10.1371\/journal.pone.0010770","article-title":"Integrative genome comparison of primary and metastatic melanomas","volume":"5","author":"Golub","year":"2010","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0749.2006.00322.x","article-title":"Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature","volume":"19","author":"Dummer","year":"2006","journal-title":"Pigment Cell Res"},{"key":"20","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Eschrich","year":"2008","journal-title":"BMC Med Genomics"},{"key":"21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1158\/1541-7786.MCR-07-0344","article-title":"Gene expression changes in an animal melanoma model correlate with aggressiveness of human melanoma metastases","volume":"6","author":"Hynes","year":"2008","journal-title":"Mol Cancer Res"},{"key":"22","first-page":"251098","article-title":"Long Noncoding RNA HOTAIR Is Associated with Motility, Invasion, and Metastatic Potential of Metastatic Melanoma","volume":"2013","author":"Yu","year":"2013","journal-title":"Biomed Res Int"},{"key":"23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djp038","article-title":"Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis","volume":"101","author":"Rimm","year":"2009","journal-title":"Journal of the National Cancer Institute"},{"key":"24","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1200\/JCO.2009.22.8239","article-title":"Melanoma prognostic model using tissue microarrays and genetic algorithms","volume":"27","author":"Rimm","year":"2009","journal-title":"J Clin Oncol"},{"key":"25","doi-asserted-by":"crossref","first-page":"e38222","DOI":"10.1371\/journal.pone.0038222","article-title":"A seven-marker signature and clinical outcome in malignant melanoma: a large-scale tissue-microarray study with two independent patient cohorts","volume":"7","author":"Landthaler","year":"2012","journal-title":"PLoS One"},{"key":"26","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1158\/1055-9965.EPI-11-0472","article-title":"Prognostic significance of cytoplasmic p27 expression in human melanoma","volume":"20","author":"Li","year":"2011","journal-title":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"27","article-title":"Role of Tip60 in Human Melanoma Cell Migration, Metastasis, and Patient Survival","author":"Li","year":"2012","journal-title":"J Invest Dermatol"},{"key":"28","article-title":"Sox4-mediated Dicer expression is critical for suppression of melanoma cell invasion","author":"Li","year":"2012","journal-title":"Oncogene"},{"key":"29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s13402-012-0080-x","article-title":"MMP2 expression is a prognostic marker for primary melanoma patients","volume":"35","author":"Li","year":"2012","journal-title":"Cellular oncology"},{"key":"30","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1038\/jid.2013.58","article-title":"Prognostic significance of Fbw7 in human melanoma and its role in cell migration","volume":"133","author":"Li","year":"2013","journal-title":"The Journal of investigative dermatology"},{"key":"31","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/bjd.12351","article-title":"Disease progression and patient survival are significantly influenced by BRAF protein expression in primary melanoma","volume":"169","author":"Li","year":"2013","journal-title":"Brit J Dermatol"},{"key":"32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/carcin\/bgt346","article-title":"Prognostic significance of KAI1\/CD82 in human melanoma and its role in cell migration and invasion through the regulation of ING4","volume":"35","author":"Li","year":"2014","journal-title":"Carcinogenesis"},{"key":"33","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2353\/ajpath.2010.100377","article-title":"Prognostic significance of Sox4 expression in human cutaneous melanoma and its role in cell migration and invasion","volume":"177","author":"Li","year":"2010","journal-title":"Am J Pathol"},{"key":"34","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Rimm","year":"2004","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1002011","article-title":"Inhibition of mutated, activated BRAF in metastatic melanoma","volume":"363","author":"Chapman","year":"2010","journal-title":"N Engl J Med"},{"key":"36","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.cell.2010.05.017","article-title":"A MicroRNA targeting dicer for metastasis control","volume":"141","author":"Bicciato","year":"2010","journal-title":"Cell"},{"key":"37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10555-011-9330-z","article-title":"Role of the ubiquitin ligase Fbw7 in cancer progression","volume":"31","author":"Li","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"38","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1016\/j.febslet.2011.08.031","article-title":"Dissecting the diverse functions of the metastasis suppressor CD82\/KAI1","volume":"585","author":"Weissman","year":"2011","journal-title":"FEBS Lett"},{"key":"39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Quigley","year":"2006","journal-title":"Cancer metastasis reviews"},{"key":"40","article-title":"p27 and Metastatic Progression: Molecular Mechanisms Underlying Bone Metastasis","author":"Wander","year":"2011","journal-title":"Open Access Dissertations"},{"key":"41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/newbio242148a0","article-title":"Selection of successive tumour lines for metastasis","volume":"242","author":"Fidler","year":"1973","journal-title":"Nat New Biol"},{"key":"42","doi-asserted-by":"crossref","first-page":"e49865","DOI":"10.1371\/journal.pone.0049865","article-title":"An attempt at a molecular prediction of metastasis in patients with primary cutaneous melanoma","volume":"7","author":"Wagner","year":"2012","journal-title":"PLoS One"},{"key":"43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1158\/1078-0432.CCR-10-0752","article-title":"p27: a barometer of signaling deregulation and potential predictor of response to targeted therapies","volume":"17","author":"Slingerland","year":"2011","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"key":"44","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0361-090X(02)00012-0","article-title":"KAI1\/CD82 protein expression in primary prostate cancer and in BPH associated with cancer","volume":"26","author":"Frauman","year":"2002","journal-title":"Cancer Detect Prev"},{"key":"45","first-page":"683963","article-title":"Expression of the Metastasis Suppressor KAI1 in Uveal Melanoma","volume":"2013","author":"Burnier","year":"2013","journal-title":"J Ophthalmol"},{"key":"46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2779","article-title":"Tetraspanins in human epithelial malignancies","volume":"223","author":"Berditchevski","year":"2011","journal-title":"J Pathol"},{"key":"47","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1074\/jbc.M110.159715","article-title":"A p27(kip1)-binding protein, p27RF-Rho, promotes cancer metastasis via activation of RhoA and RhoC","volume":"286","author":"Seiki","year":"2011","journal-title":"J Biol Chem"},{"key":"48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrc2347","article-title":"The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy","volume":"8","author":"Slingerland","year":"2008","journal-title":"Nature reviews Cancer"},{"key":"49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1001\/archdermatol.2011.264","article-title":"The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007","volume":"148","author":"Weinstock","year":"2012","journal-title":"Arch Dermatol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T20:57:45Z","timestamp":1653166665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.4854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,14]]},"references-count":49,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2015,9,9]]}},"alternative-id":["4854","26246476"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.4854","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,14]]}}}